?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Archives:
Resources
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
June 6, 2022
signalgroup
Biosimilars 101 Webinar Case Study
June 1, 2022
signalgroup
Biosimilars Forum Comments on PBM Business Practices
April 25, 2022
signalgroup
Saving Billions on Healthcare Costs with Biosimilars
April 13, 2022
signalgroup
Biosimilars Basics
September 15, 2021
signalgroup
Separate Codes and Payment for Biosimilars
June 14, 2021
signalgroup
Biosimilars Have Significantly Lowered Prices of All Biologics
August 18, 2020
signalgroup
Biosimilars Forum Economic Footprint
November 11, 2019
signalgroup
Polling Shows Strong Bipartisan Support for Immediate Action on Biosimilars to Reduce Health Care Costs
October 3, 2019
signalgroup
FDA Patient Materials
July 3, 2019
Katie Quinn
State Laws and Biosimilars
01
02
03
04